The model also suggests that COVID-19 deaths could fall from around 2,000 per day to fewer than 60 per day by mid-March.
Customers toast on the Eataly Flatiron Rooftop in New York City on April 15, 2021.A new model suggests the US's COVID-19 cases and deaths aren't likely to climb higher between now and March.But hospitals might still be strained in states with cold climates or low vaccination rates.The pandemic has thrown its share of curveballs, but a new model suggests that US COVID-19 cases aren't likely to climb any higher for the foreseeable future, and COVID-19 deaths should steadily decline.
The model is an average of nine different projections. It assumes that young kids will get vaccinated at the same rate as teenagers once the vaccine is authorized for them, and that Delta will remain the most transmissible variant.from the University of Washington's Institute for Health Metrics and Evaluation anticipates that daily infections - including ones that aren't picked up by tests - could rise in November after a decline in October.
"Unless we have another, even more transmissible variant, we shouldn't expect any future surge to be as intense as this one," Jeffrey Morris, director of biostatistics at the University of Pennsylvania,
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Covid-19: NI records eight Covid-linked deaths, 1,030 casesThe total number of deaths with coronavirus in NI since the start of the pandemic is 2,533.
Read more »
U.S. court upholds hospital employee COVID-19 vaccine rule in test caseA federal judge on Friday ruled that a Cincinnati, Ohio-area healthcare provider could require its employees get vaccinated against COVID-19 or risk losing their job, in what appears to be the first ruling of its kind for a private employer in the United States.
Read more »
CDC Panel Outlines Who Should Get Pfizer-BioNTech COVID-19 Boosters, And Who Should WaitThe panel limited the additional dose to people who have already been vaccinated with the Pfizer-BioNTech COVID-19 vaccine
Read more »
FDA authorizes Pfizer COVID-19 booster shots for someThe Food and Drug Administration granted emergency use authorization Wednesday for a third dose of Pfizer and BioNTech's COVID-19 vaccine to be given to three groups.
Read more »
FDA backs Pfizer COVID-19 boosters for seniors, high-riskThe U.S. moved a step closer Wednesday to offering booster doses of Pfizer’s COVID-19 vaccine to senior citizens and others at high risk from the virus as the Food and Drug Administration signed off on the targeted use of extra shots. The FDA authorized booster doses for Americans who are 65 and older, younger adults with underlying health conditions and those in jobs that put them at high risk for COVID-19.
Read more »